Latest News of GMAB
Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
6 days ago
Genmab A/S released new data on the Phase 1/2 study of rinatabart sesutecan (Rina-S), showing a 50% ORR in ovarian cancer patients treated with Rina-S....
Genmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
By Yahoo! Finance |
4 weeks ago
Genmab A/S (NASDAQ: GMAB) is a biotech company focused on cancer treatments. It ranks 4th on the list of affordable stocks under $40 according to short sellers....